TRIA Preps FDA Submission For OTC Skin Rejuvenating Laser, Files For IPO
This article was originally published in The Tan Sheet
Executive Summary
The aesthetic device maker plans to file a 510(k) this year with FDA for its OTC, non-ablative laser to treat facial wrinkles, supported in part by proceeds from an IPO worth up to $86.3 million. The hand-held device restricts a laser beam to fine “spot sizes” surrounded by untreated tissue.
You may also be interested in...
TRIA Beauty Alleges Laser Hair-Removal Center Mislead Customers, Files Suit
Aesthetic device maker TRIA Beauty is bringing a lawsuit against Phoenix Rising Laser, which made "erroneous statements" about TRIA's at-home hair-removal system, according to its July 21 release
Emerging Markets Bring Risks That Require More Supply Chain Visibility – Report
Industry survey outlines challenges of globalization cited by medtech execs, including potential for insufficient supply chain visibility. Report suggests IT improvements and “on-demand visibility” solutions could help iron out the kinks.
Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax
Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.